Bristol-Myers Squibb Market Cap 2006-2019 | BMY

Bristol-Myers Squibb market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Bristol-Myers Squibb market cap as of May 22, 2019 is $77.58B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $77.582B $22.561B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $370.562B 16.80
Pfizer (PFE) United States $248.056B 13.53
Merck (MRK) United States $214.347B 17.63
Novartis AG (NVS) Switzerland $190.321B 16.44
AbbVie (ABBV) United States $119.568B 9.89
Novo Nordisk (NVO) Denmark $116.141B 19.32
Eli Lilly (LLY) United States $113.179B 21.00
Sanofi (SNY) France $103.283B 12.67
GlaxoSmithKline (GSK) United Kingdom $97.711B 12.39
AstraZeneca (AZN) United Kingdom $95.946B 11.04